Seyffert, Jennifer, and William Steffes. 2019. “Vitiligo Following Alemtuzumab Therapy in Multiple Sclerosis: A Demonstration of Secondary Autoimmunity”. International Journal of Research in Dermatology 5 (4):882-84. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20194687.